Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Research In Motion (RIMM) stock vulnerable to more selling

Continued improvement in the global economy helped propel Wall Street to rather impressive gains last year. The Dow Jones Industrial Average (DJIA) added 18.8% for the year, while the S&P 500 Index (SPX) vaulted some 23.5% higher. The Nasdaq Composite (COMP), however, put it...
Joseph Hargett | October 28, 2012 |

Western Refining (WNR): Pessimism has primed the pump for a rally

Independent crude oil refiner Western Refining Inc. ( NYSE: WNR ) is slated to step into the earnings limelight ahead of the open on Thursday, Nov. 4. Currently, Wall Street is looking for a profit of 12 cents per share from the company, a vast improvement over WNR's loss ...
Joseph Hargett | October 28, 2012 |

17 best payday loans online: Quick cash and fast approval this Christmas

If you face a financial emergency, traditional loans may not be a viable option if you have bad credit. So what can you do when you need quick cash – especially close if you need cash for Christmas gifts during the festive season? The best online payday loans are an a...
Dominic Castleberry | December 11, 2023 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...
Streetwise Reports | May 28, 2020 |

Deere & Company (DE) stock could run on options-related support

Tractor titan Deere & Company ( NYSE: DE , Stock Forum ) kicked off the week with an optimistic analyst note, with Wells Fargo upgrading the stock to "outperform" from "market perform." Furthermore, the analysts said the company's construction and forestry segments should...
Andrea Kramer | October 28, 2012 |

Technical Analyst: Significant Correction for Gold Has Started

Technical analyst Clive Maund discusses the factors he sees pulling gold down. Although a major precious metals sector bull market has certainly started, various fundamental and technical factors came together last week to suggest that a significant correction to the ...
Streetwise Reports | September 10, 2019 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |
1 2 3 4 5 6 7 8 9 10 ...